5[1]Egorin MJ. Cancer pharmacology in the elderly. Semin Oncol,1993,20(1):43-49.
6[2]Vose JM. Cytokine use in the older patient.Semin Oncol,1995,22(1 suppll):6-8.
7[3]Cohen HJ.Geriatric principles of treatment applied to medical oncology .an overview.Semin Oncol,1995,22(1 sup.):1-2.
8[4]Oshita F,Kurata T,KasaiT,et al. Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions. Jpn.J.Cancer Res,1995,86(12):1198-1202.
9[5]Sweebey CJ, Sabdker AB. Treatment of advanced (stageⅢ andⅣ) non-small cell lung cancer.Curr Probl Cancer,1998,22(2):87-132.
5Maranzano E,Crino L,Pirom F,et al.Long-term results of induction chemotherapy followed by concurrent chemotherapy and thoracic irradiation in limited small cell lung cancer[J].Lung-Cancer, 2002,37(1):79-85.
6Belani CP.Recent updates in the clinical use of platinum compounds for the treatment of lung,breast,and genitourinary tumors and myeloma[J].Semin Oncol,2004,31(6 Suppl 14):25-33.
7Sundstrom S,Bremnes RM,Kaasa S,et al.Cisplatin and etoposide regimen is superior to cyclophosphamide,epirubicin,and vincristine regimen in small-cell lung cancer: results from a randomized phase Ⅲ trial with 5 years follow-up [J].J Clin Oncol, 2002,20(24):4665-4672.
8Mavroudis D,Papadakis E,Veslemes M,et al.A muhicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer [J].Ann Oncol,2001,12(4):463-470.
9Noda K,Dawahara M,Tanaka N,et al.lrinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small cell lung cancer[J].N Engl J Med,2002,346:85-91.
10Gridelli C,Rossi A,Barletta E,et al.Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensivestage small-cell lung cancer: a poorly tolerated regimen.Resuits of a multicentre phase II study [J].Lung Cancer,2002,36(3):327-332.
